Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products read more
Santen Pharmaceutical VP of Investor Relations Salary
The average Santen Pharmaceutical VP of Investor Relations earns an estimated $128,113 annually. Santen Pharmaceutical's VP of Investor Relations compensation is $3,295 less than the US average for a VP of Investor Relations.
Last updated 4 years ago.
$77k
$120k
$129k
$225k
$128,113
Average Compensation
- $128,113
- avg. base
VP of Investor Relations Salaries at Santen Pharmaceutical
Compensation at Santen Pharmaceutical by Department
How VPs of Investor Relations at Santen Pharmaceutical Rate Their Compensation
The majority of VPs of Investor Relations at Santen Pharmaceutical believe they're not compensated fairly. 50% of VPs of Investor Relations at Santen Pharmaceutical say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Santen Pharmaceutical
VP of Investor Relations Salaries at Similar Size Companies
×